Adaptive Biotechnologies Reports 55% Revenue Growth and Sharp Rise in clonoSEQ Testing Volume for 2025
Market Chameleon (Mon, 12-Jan 8:16 AM)
Adaptive Biotechnologies and Pfizer Forge Major Partnerships Targeting Rheumatoid Arthritis and Immunology Data Applications
Market Chameleon (Mon, 15-Dec 9:26 AM)
clonoSEQ MRD Test Featured in 89 Abstracts at ASH 2025—Expanding Role in Blood Cancer Care
Market Chameleon (Mon, 24-Nov 9:17 AM)
